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Background
In the Total Body Hypothermia for Neonatal Encephalopathy Trial (TOBY), newborns 
with asphyxial encephalopathy who received hypothermic therapy had improved 
neurologic outcomes at 18 months of age, but it is uncertain whether such therapy 
results in longer-term neurocognitive benefits.
Methods
We randomly assigned 325 newborns with asphyxial encephalopathy who were born 
at a gestational age of 36 weeks or more to receive standard care alone (control) or 
standard care with hypothermia to a rectal temperature of 33 to 34°C for 72 hours 
within 6 hours after birth. We evaluated the neurocognitive function of these chil-
dren at 6 to 7 years of age. The primary outcome of this analysis was the frequency 
of survival with an IQ score of 85 or higher.
Results
A total of 75 of 145 children (52%) in the hypothermia group versus 52 of 132 (39%) in 
the control group survived with an IQ score of 85 or more (relative risk, 1.31; P = 0.04). 
The proportions of children who died were similar in the hypothermia group and 
the control group (29% and 30%, respectively). More children in the hypothermia 
group than in the control group survived without neurologic abnormalities (65 of 145 
[45%] vs. 37 of 132 [28%]; relative risk, 1.60; 95% confidence interval, 1.15 to 2.22). 
Among survivors, children in the hypothermia group, as compared with those in the 
control group, had significant reductions in the risk of cerebral palsy (21% vs. 36%, 
P = 0.03) and the risk of moderate or severe disability (22% vs. 37%, P = 0.03); they 
also had significantly better motor-function scores. There was no significant be-
tween-group difference in parental assessments of children’s health status and in 
results on 10 of 11 psychometric tests.
Conclusions
Moderate hypothermia after perinatal asphyxia resulted in improved neurocogni-
tive outcomes in middle childhood. (Funded by the United Kingdom Medical Re-
search Council and others; TOBY ClinicalTrials.gov number, NCT01092637.)
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Perinatal asphyxial encephalopathy is associated with a high risk of death or ear-ly neurodevelopmental impairment. Among 
survivors, cerebral palsy, functional disability, and 
cognitive impairment often develop later in child-
hood. The cost of this condition to patients, their 
families, and society is high.
In several randomized, controlled trials in-
volving infants with clear evidence of asphyxial 
encephalopathy, moderate hypothermia (33 to 34°C) 
for 72 hours, initiated within 6 hours after deliv-
ery, has been shown to reduce the risk of death 
or disability at 18 to 24 months of age and to 
increase the rate of survival free of disability.1 
The observation that hypothermia reduces the 
proportion of infants with abnormalities as seen 
on neuroimaging supports the hypothesis that 
early improvements in outcome should persist.2 
However, early assessment of neurodevelopmental 
outcomes may be altered on later follow-up, when 
more precise assessment is possible, and improve-
ments observed in the short term may be only 
temporary.3,4 Data on long-term outcomes after 
neonatal hypothermia are lacking. In one previ-
ous study of neurologic outcomes at the age of 
6 to 7 years in children who had been treated 
with hypothermia soon after birth, the children 
in the hypothermia group had an increased rate 
of survival as compared with those in the con-
trol group, but there was no significant between-
group difference in the rate of the composite 
primary end point of death or an IQ score lower 
than 70 (46 of 97 children [47%] in the hypo-
thermia group vs. 58 of 93 [62%] in the control 
group; relative risk in the hypothermia group, 0.78; 
95% confidence interval [CI], 0.61 to 1.01).5 In 
addition, there were no significant reductions 
in other neurodevelopmental disabilities.
The Total Body Hypothermia for Neonatal 
Encephalopathy Trial (TOBY) was a large, random-
ized, controlled trial of hypothermia for perinatal 
asphyxial encephalopathy.6 At 18 months, children 
who had been treated with hypothermia had 
reduced risks of cerebral palsy and improved 
scores on the Mental Developmental Index and 
Psychomotor Developmental Index of the Bayley 
Scales of Infant Development II (BSID-II) and on 
the Gross Motor Function Classification System.6 
Here we report the results of evaluation of the 
study population at 6 to 7 years of age to deter-
mine whether the use of moderate hypothermia 
after perinatal asphyxia is associated with longer-
term benefits. The primary outcome was the 
frequency of survival with an IQ score of 85 or 
higher at 6 to 7 years, as assessed with the use 
of standardized tests.
Me thods
Study Design
In the TOBY trial, 325 infants with a gestational 
age of at least 36 weeks who had moderate-to-
severe asphyxial encephalopathy and abnormal re-
sults on amplitude-integrated electroencephalogra-
phy (EEG) were randomly assigned within 6 hours 
after birth to receive standard care alone (con-
trol) or standard care with hypothermia to a rec-
tal temperature of 33 to 34°C for 72 hours, followed 
by slow rewarming. Hypothermia was maintained 
by nursing the infant on a cooling blanket. The 
children were enrolled in the study from 2002 to 
2006, and follow-up at 6 to 7 years was conducted 
from 2009 to 2013.
The National Research Ethics Service in the 
United Kingdom and the relevant ethics review 
board at each of the institutions outside the 
United Kingdom approved the TOBY protocol 
(available with the full text of this article at 
NEJM.org), and an independent trial steering 
committee oversaw the study. Written informed 
consent was obtained from the children’s parents.
A letter of invitation, together with an infor-
mation leaflet and consent form, was mailed to 
the parents of surviving children. After parental 
consent had been obtained, a psychologist and a 
pediatrician, both of whom were unaware of the 
study-group assignments, performed the assess-
ments, usually at the child’s school. The assessment 
comprised a neurologic examination and a neuro-
psychological assessment encompassing sensory 
function, cognition, memory, attention, and ex-
ecutive function, all areas that are likely to be af-
fected by perinatal asphyxia. Questionnaire re-
sponses were requested from parents and teachers.
Neurologic Examination
A structured neurologic examination to detect 
signs of cerebral palsy and minor neurologic dys-
function was performed.7,8 Neuromotor function 
was assessed with the use of the Gross Motor 
Function Classification System and the Manual 
Ability Classification System; scores on the two 
assessments range from 1 to 5, with higher 
scores indicating greater impairment.9,10
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Psychometric Assessment
We used the Wechsler Preschool and Primary Scale 
of Intelligence III (WPPSI-III) test or the Wechsler 
Intelligence Scale for Children IV (WISC-IV), stan-
dardized for children in the United Kingdom (2004) 
or as appropriate in other countries, to evaluate 
general cognitive performance.11 Results on these 
two tests include a general measure of IQ (the 
primary outcome) with quotients for verbal and 
nonverbal performance and processing speed. All 
results are expressed as an age-standardized score, 
with a population mean of 100 and a standard 
deviation of 15.
Other Assessments
We also administered age-appropriate subtests 
selected from the following domains of the De-
velopmental Neuropsychological Assessment II 
(NEPSY-II): attention and executive function, vis-
uo spatial processing, sensorimotor function, and 
memory and learning.12 We report the mean scores 
for each domain, derived from the mean stan-
dardized subset scores.
Since deficits in working memory have been 
reported in children after neonatal encephalopathy 
and hypoxia,13,14 we also assessed scores from 
the following three subtests of the Working 
Memory Test Battery for Children: block recall, to 
assess nonverbal short-term memory; digit recall, 
to assess verbal short-term memory; and backward 
digit recall, to assess central executive function.15
Parents and teachers, who were aware of study-
group assignments, completed the Strengths and 
Difficulties Questionnaire (www.sdqinfo.com) (on 
a scale of 0 to 40, with higher scores indicating 
more difficulties) and the Attention Deficit–Hyper-
activity Disorder (ADHD) Rating Scale IV (on a scale 
of 0 to 54, with higher scores indicating more se-
vere symptoms).16 Appropriate translations were 
available for the European centers. Parents were 
also asked to complete questionnaires assessing 
their child’s behavior, everyday memory, use of 
health care services, and demographic informa-
tion and provided information about their child’s 
health status with the use of the Health Utilities 
Index (HUI) as proxy respondents. We converted 
the responses into multi-attribute utility scores 
using published algorithms (HUI2 and HUI3); 
these range from −0.03 to 1.00 for HUI2 and 
from −0.36 to 1.00 for HUI3; the lowest score 
represents the utility of the worst possible state, 
with 0.00 indicating death and 1.00 perfect health, 
although negative scoring is possible. A change 
of 0.03 points in the mean overall score is con-
sidered to be clinically meaningful.17,18
We obtained permission from parents to re-
quest information about educational attainment 
from the child’s school. Teachers and parents 
then completed two detailed questionnaires — 
the Total Academic Achievement Score19 and the 
Strengths and Difficulties Questionnaire (with 
the latter including responses from both teachers 
and parents) — and provided information about 
any special educational needs.
Study Outcomes
The primary outcome was the frequency of sur-
vival with an IQ score of 85 or higher (1 SD below 
the standardized mean IQ score for the general 
population). Other prespecified outcomes were 
components of the primary outcome; the frequen-
cy of survival without neurologic abnormalities, 
which was defined as an IQ score of 85 or higher, 
a normal neurologic examination, normal vision, 
and normal hearing; the full-scale IQ score and 
subscale scores on the WPPSI-III or WISC-IV; 
NEPSY-II domain scores; overall memory score; 
score for total difficulties from the parental ques-
tionnaire; overall ADHD rating; prevalence of ce-
rebral palsy; scores for gross motor function and 
manual ability; the grade of disability, which was 
categorized as mild disability (an IQ score of 70 to 
84, level 1 gross motor function [is able to walk 
independently but may have some gait abnormal-
ities], or abnormality in one or both eyes with nor-
mal or nearly normal vision), moderate disability 
(an IQ score of 55 to 69, level 2 or 3 gross motor 
function [has minimal ability to perform gross 
motor skills or requires assistance with walking], 
or moderately reduced vision), or severe disability 
(an IQ score of <55, level 4 or 5 gross motor func-
tion [needs adaptive seating or has severely lim-
ited mobility], or no useful vision); teacher’s 
score for academic achievement; and score on the 
Health Utility Index (HUI2 and HUI3).
Partial Assessments and Missing Data
Two assessors who were unaware of the study-
group assignments independently classified the 
children with missing or incomplete results on 
the WPPSI-III or WISC-IV into two IQ groups 
(<85 or ≥85) on the basis of additional informa-
tion that was available. Children were classified 
into the group with an IQ score of 85 or higher if 
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they had an IQ score of 85 or higher on any full 
subscale of the WPPSI-III and were unable to com-
plete the other sections because of physical im-
pairments. We included these children’s adjudi-
cated outcomes in the primary outcome analysis.
For any partially completed scores on the 
Strengths and Difficulties Questionnaire and 
ADHD ratings from parents and teachers, pro 
rata estimation was used if 10% or less of the 
items were missing (i.e., up to two items miss-
ing on each scale). Children for whom we had no 
information after the 18-month assessment were 
not included in the primary outcome analysis.
Sensitivity Analyses
We used two tests to explore the sensitivity of the 
primary outcome to missing data. In the first 
test, we assigned nonparticipants an IQ score of 
85 or higher at the age of 6 to 7 years for those 
with a Mental Developmental Index of 85 or 
higher at 18 months and an IQ score of less than 
85 for those with a Mental Developmental Index 
of less than 85 at 18 months. In the second test, 
we assigned participating children who were 
unable to complete the full-scale WPPSI-III or 
WISC-IV to the group with an IQ score lower 
than 85.
Table 1. Demographic and Clinical Characteristics of the Children at Trial Entry.*
Characteristic Outcomes at 6 to 7 Years Available
Outcomes at 
6 to 7 Years  
Not Available
Hypothermia Group
(N = 145)
Control Group
(N = 135)
All Children
(N = 280)
All Children
(N = 45)
Male sex — no. (%) 91 (63) 74 (55) 165 (59) 24 (53)
Gestational age
Median (IQR) — wk 40.3 (39.3–41.3) 40.1 (39.0–41.1) 40.2 (39.0–41.1) 40.0 (37.7–41.1)
Missing data — no. 16 16 32 1
Birth weight
Median (IQR) — g 3467 (3053–3883) 3351 (3060–3700) 3428 (3055–3790) 3142 (2740–3790)
Missing data — no. 1 1 2 0
Age at randomization — no. (%)
<4 hr 45 (31) 52 (39) 97 (35) 8 (18)
4–6 hr 100 (69) 83 (61) 183 (65) 37 (82)†
Maternal pyrexia during labor — no./
total no. (%)
10/143 (7) 9/131 (7) 19/274 (7) 1/43 (2)
Delivery complications — no./total no. 
(%)
102/143 (71) 98/133 (74) 200/276 (72) 34/45 (76)
Apgar score ≤5 at 10 min — no./ 
total no. (%)
98/117 (84) 88/113 (78) 186/230 (81) 29/38 (76)
Clinical seizures — no./total no. (%) 84/141 (60) 66/130 (51) 150/271 (55) 25/43 (58)
Temperature at randomization
Mean — °C 36.6±1.1 36.4±1.2 36.5±1.1 36.9±1.0†
Missing data — no. 0 2 2 0
Abnormalities on aEEG at random-
ization — no. (%)
Moderate 62 (43) 57 (42) 119 (42) 13 (29)
Severe 83 (57) 78 (58) 161 (58) 32 (71)
* Plus–minus values are means ±SD. There were no significant differences between the hypothermia group and the con-
trol group among children for whom follow-up data were available. The abbreviation aEEG denotes amplitude-integrat-
ed electroencephalography, and IQR denotes interquartile range.
† P<0.05 for the comparison with children who had available outcomes at 6 to 7 years.
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Statistical Analysis
We calculated relative risks and 95% confidence 
intervals on the basis of the proportion of chil-
dren with an IQ score of 85 or higher and the 
proportions with secondary outcomes at the age 
of 6 or 7 years in the hypothermia group, as com-
pared with the control group. We prespecified a 
test of interaction between treatment and abnor-
mality on amplitude-integrated EEG, which pro-
vides an index of the severity of the asphyxial 
insult, and examined the effect of maternal educa-
tion (classified according to whether the mother 
had graduated from high school) on the primary 
outcome.
For normally distributed continuous outcomes, 
we present means and standard deviations for 
each group and the mean between-group differ-
ences plus 95% confidence intervals. For non-
Gaussian distributions, we present the median 
and interquartile range for each group.
A two-sided P value of less than 0.05 was 
considered to indicate statistical significance. 
No adjustment was made for multiple testing of 
the secondary outcome measures.
R esult s
Patients
Outcome data were available for 280 children 
(184 survivors and 96 children who died before 
the assessment at 6 to 7 years of age). Of these 
children, 245 (88%) were from the United King-
dom, and the rest were from other countries. Pa-
rental educational level and socioeconomic sta-
tus were similar in the two study groups, and the 
clinical characteristics of the children were simi-
lar at trial entry (Table 1; and Tables S1 through 
S4 in the Supplementary Appendix, available at 
NEJM.org). A total of 45 children did not par-
ticipate in the follow-up study and were exclud-
ed from the primary analysis (Fig. 1). As com-
pared with participants, nonparticipants had a 
higher rectal temperature at the time of ran-
domization, were significantly less likely to en-
ter the study within 4 hours after birth, and had 
a higher frequency of severe abnormalities on 
amplitude-integrated EEG, although the last dif-
ference was not significant; at 18 months, non-
participants had lower scores on the Mental De-
velopmental Index.
Primary Outcome
Of the 184 surviving children who participated 
in the follow-up evaluation, 140 underwent full-
scale IQ testing with the WPPSI-III or the WISC-IV. 
Another 41 children (18 in the hypothermia group 
and 23 in the control group) were unable to com-
plete the test, in most cases because of physical 
impairment (37 children) or because they would 
not cooperate. Of the 41 children who did not 
325 Infants underwent randomization
163 Were assigned to the hypothermia
group
162 Were assigned to the control group
18 Were lost to follow-up 27 Were lost to follow-up
49 Died by 6–7 yr of age
86 Were included in follow-up at 6–7 yr
47 Died by 6–7 yr of age
98 Were included in follow-up at 6–7 yr
3 Did not have IQ classified
145 Were included in primary analysis 132 Were included in primary analysis
Figure 1. Enrollment and Outcomes.
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Table 2. Primary Outcome and Its Components in Children 6 to 7 Years of Age.*
Hypothermia Group
(N = 163)
Control Group
(N = 162)
Relative Risk
(95% CI) P Value
Survival with IQ score ≥85 among 
all children who could be tested 
— no./total no. (%)
75/145 (52) 52/132 (39) 1.31 (1.01–1.71) 0.04
Death — no./total no. (%) 47/163 (29) 49/162 (30) 0.95 (0.68–1.33) 0.81
IQ score ≥85 among survivors — 
no./total no. (%)
75/98 (77) 52/83 (63) 1.22 (1.00–1.49) 0.05
* IQ scores could not be determined for 18 children in the hypothermia group and 30 in the control group. There was no 
significant interaction between treatment and results on amplitude-integrated EEG (risk ratio, 0.99; 95% CI, 0.59 to 1.67; 
P = 0.97).
Table 3. Pediatric Assessment in Survivors.
Variable Hypothermia Group Control Group
Relative Risk
(95% CI) P Value
no./total no. (%)
Grade of disability*
No disability 65/96 (68) 37/83 (45) 1.52 (1.15–2.00) 0.002
Mild disability 10/96 (10) 15/83 (18)
Moderate disability 8/96 (8) 11/83 (13)
Severe disability 13/96 (14) 20/83 (24)
Moderate or severe disability 21/96 (22) 31/83 (37) 0.59 (0.37–0.94) 0.03
Cerebral palsy† 21/98 (21) 31/86 (36) 0.59 (0.37–0.95) 0.03
Score on Gross Motor Function Classification 
System‡
No abnormality 76/98 (78) 49/83 (59) 1.31 (1.07–1.62) 0.01
Level 1–2 6/98 (6) 13/83 (16)
Level 3–5 16/98 (16) 21/83 (25) 0.65 (0.36–1.15) 0.14
Score on Manual Ability Classification System§ 
No abnormality 75/98 (77) 51/83 (61) 1.25 (1.02–1.53) 0.04
Level 1–2 4/98 (4) 8/83 (10)
Level 3–5 19/98 (19) 24/83 (29) 0.67 (0.40–1.13) 0.16
Visual impairment not corrected by eyeglasses 7/98 (7) 10/82 (12) 0.59 (0.23–1.47) 0.31
Blindness 1/98 (1) 1/82 (1) 0.84 (0.05–13.17) 1.00
Hearing impairment 4/98 (4) 8/83 (10) 0.42 (0.13–1.36) 0.15
* Two children in the hypothermia group could not be classified. P = 0.002 for trend.
† Two children in the hypothermia group and two in the control group could not be classified and were subsequently 
found not to have cerebral palsy.
‡ Scoring on the Gross Motor Function Classification System is as follows: level 1, able to walk independently but may 
have some gait abnormalities; level 2, able to walk in most settings but with only minimal ability to perform gross mo-
tor skills such as running and jumping; level 3, walks with handheld assistive device and when seated may need seat 
belt for balance; level 4, requires physical assistance or powered mobility and needs adaptive seating; and level 5, se-
verely limited in mobility, with limited ability to maintain antigravity head and trunk postures. P = 0.01 for trend.
§ Scoring on the Manual Ability Classification System is as follows: level 1, handles objects easily and successfully; level 2, 
handles most objects but with somewhat reduced quality or speed of achievement; level 3, handles objects with diffi-
culty; needs help to prepare or modify activities; level 4, handles a limited selection of easily managed objects in adapt-
ed situations; level 5, does not handle objects and has severely limited ability to perform even simple actions. P = 0.04 
for trend.
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undergo full-scale IQ testing, 35 (15 in the hypo-
thermia group and 20 in the control group) were 
classified as having an IQ score lower than 85; 
3 children in each group were classified as hav-
ing an IQ score of 85 or higher by the expert as-
sessors. For another 3 children, information was 
available from the parents only, and the IQ score 
could not be classified. Ultimately, 277 of 325 chil-
dren in the TOBY population (85%) were included 
in the primary analysis. Scores on the Mental De-
velopmental Index at 18 months were available 
for 39 children who were lost to follow-up at 6 to 
7 years of age, and thus 316 children were in-
cluded in the sensitivity analysis that relied on 
earlier data for children for whom a current IQ 
measurement was missing.
The frequency of survival with an IQ score of 
85 or higher was 52% (75 of 145 children) in 
the hypothermia group as compared with 39% 
(52 of 132 children) in the control group (rela-
tive risk, 1.31; 95% CI, 1.01 to 1.71; P = 0.04) 
(Table 2). The number of children who would 
need to be treated with hypothermia in order to 
prevent 1 child from dying or having an IQ 
score lower than 85 was 8 (95% CI, 4 to 145). 
There was no significant interaction between 
treatment and grade of abnormality on ampli-
tude-integrated EEG (P = 0.97). The results of 
Table 4. Psychometric Assessment in Survivors.*
Hypothermia Group
(N = 98)
Control Group
(N = 86)
Difference in Means
(95% CI) P Value
Intelligence†
Full-scale IQ score
Mean 103.6±14.4 98.5±18.9 5.1 (−0.4 to 10.6) 0.07
Missing data (no.) 18 25
Verbal IQ score
Mean 105.2±15.6 101.1±17.3 4.0 (−1.6 to 9.5) 0.16
Missing data (no.) 21 25
Nonverbal performance score
Mean 101.1±15.0 96.7±19.0 4.4 (−1.2 to 10.1) 0.12
Missing data (no.) 19 22
Processing speed score
Mean 98.7±12.4 95.3±18.7 3.4 (−2.0 to 8.9) 0.22
Missing data (no.) 25 31
Score on Developmental Neuropsycho-
logical Assessment‡
Attention and executive function
Mean 9.6±2.1 8.6±2.7 1.02 (0.12 to 1.92) 0.03
Missing data (no.) 32 38
Memory and learning
Mean 10.0±2.2 9.4±2.8 0.58 (−0.28 to 1.44) 0.18
Missing data (no.) 22 33
Sensorimotor processing
Mean 8.1±2.6 7.1±2.7 0.97 (−0.05 to 1.91) 0.06
Missing data (no.) 27 38
Visuospatial processing
Mean 10.4±3.1 9.6±3.5 0.82 (−0.35 to 2.0) 0.17
Missing data (no.) 23 34
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an analysis adjusted for maternal educational 
level were materially unchanged, as were the 
results of a sensitivity analysis that included 
data from nonparticipants (relative risk, 1.31; 
95% CI, 1.02 to 1.67) and a sensitivity analysis 
that included children who were not able to com-
plete IQ testing and were assigned to the group 
with an IQ score lower than 85 (relative risk, 
1.37; 95% CI, 1.04 to 1.80) (Tables S5 through S8 
in the Supplementary Appendix).
Other Outcomes
The rates of death did not differ significantly 
between the hypothermia group (in which 47 of 
163 children [29%] died) and the control group 
(in which 49 of 162 children [30%] died) (Table 2). 
A total of 86 of the 96 deaths (90%) occurred 
before the 18-month assessment. A higher pro-
portion of survivors in the hypothermia group 
than in the control group had an IQ score of 85 
or higher (77% vs. 63%; relative risk, 1.22; 95% 
CI, 1.00 to 1.49; P = 0.05) (Table 2). Significantly 
more children in the hypothermia group than in 
the control group survived without neurologic 
abnormalities (65 of 145 [45%] vs. 37 of 132 [28%]; 
relative risk, 1.60; 95% CI, 1.15 to 2.22) (Table S9 
in the Supplementary Appendix). Among survivors, 
children in the hypothermia group had significantly 
reduced rates of cerebral palsy (21% vs. 36%, 
P = 0.03) and moderate or severe disability (22% vs. 
37%, P = 0.03) and had significantly better scores 
for gross motor function and manual ability 
 (Table 3). The rates of visual and hearing impair-
ments did not differ significantly between the 
two groups, and head circumference and growth 
were similar in the two groups (Table S10 in the 
Supplementary Appendix).
Approximately 30% of children did not com-
plete the psychometric tests. Among the children 
who completed the psychometric tests, there was 
no significant between-group difference with 
respect to IQ scores that were measured on a 
continuous scale and other scores, with the ex-
ception of 1 of the 11 scores compared (atten-
tion and executive function, P = 0.03) (Table 4). 
There were also no significant differences be-
tween groups in mean scores on the index of 
health care status derived from parental assess-
ments (HUI2 and HUI3) or in parental scores for 
children’s strengths and difficulties and ADHD 
Table 4. (Continued.)
Hypothermia Group
(N = 98)
Control Group
(N = 86)
Difference in Means
(95% CI) P Value
Score on the Working Memory Test Bat-
tery for Children§
Digit recall
Mean 104.1±17.3 106.1±15.3 −2.0 (−8.3 to 4.3) 0.54
Missing data (no.) 36 39
Block recall
Mean 97.0±18.3 94.7±15.6 2.3 (−4.3 to 8.9) 0.49
Missing data (no.) 36 39
Backward digit recall
Mean 96.1±15.4 95.3±15.2 0.7 (−5.3 to 6.7) 0.81
Missing data (no.) 38 41
* Plus–minus values are means ±SD. A positive between-group difference favors the hypothermia group, and a negative 
difference favors the control group.
† Intelligence was measured with the use of the Wechsler Preschool and Primary Scale of Intelligence III(WPPSI-III) or 
the Wechsler Intelligence Scale for Children IV (WISC-IV). Each score on the WPPSI-III and WISC-IV is standardized to 
have an average of 100, with scores of 115 and 85 representing 1 SD above and below the mean.
‡ Each subscale on the Developmental Neuropsychological Assessment II (NEPSY-II) ranges from 1 to 19, and a score of 
5 or less is equivalent to a percentile rank below 25, which is below the expected level of ability for the child’s age.
§ Scores on the Working Memory Test Battery for Children are standardized in the same manner as are scores on the 
WPPSI-III and WISC-IV.
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scores (Tables S9, S10, and S11 in the Supple-
mentary Appendix).
The mean difference in the academic achieve-
ment score favored the hypothermia group but 
was not significant. The proportion of children 
who required use of special educational resourc-
es was lower in the hypothermia group than in 
the control group (8.2% vs. 26.9%; relative risk, 
0.30; 95% CI, 0.12 to 0.79; P = 0.01) (Table S12 in 
the Supplementary Appendix).
Discussion
Children with asphyxial encephalopathy who 
were treated with hypothermia shortly after birth 
were significantly more likely to survive with an 
IQ score of 85 or higher at 6 to 7 years of age 
than were children who did not undergo such 
therapy. Similar proportions of children in the 
two groups died, but a higher proportion of sur-
vivors in the hypothermia group had an IQ score 
of 85 or higher, and the frequency of moderate-
to-severe disability was lower in this group than 
in the control group.
Data are lacking with respect to longer-term 
outcomes after hypothermia therapy for perinatal 
asphyxia. The CoolCap study, which evaluated 
the efficacy of selective head cooling on the ba-
sis of questionnaire data from parents of 62 of 
135 children (46%) at 7 to 8 years of age, showed 
that childhood outcomes broadly correlated with 
the 18-month assessments, although the study 
was underpowered to examine the effect of hypo-
thermia on cognitive function at an older age.20 
In the Childhood Outcomes after Hypothermia 
for Neonatal Encephalopathy study, sponsored by 
the Eunice Kennedy Shriver National Institute of 
Child Health and Human Development (NICHD), 
there was a high follow-up rate among children 
6 to 7 years of age, with children in the hypo-
thermia group having a lower rate of death than 
those in the control group. However, the study 
showed no significant differences in rates of dis-
ability or cognitive outcomes, perhaps because of a 
lack of statistical power.5 In our study, in which we 
used the same psychometric tests as were used in 
the NICHD study but used a different cutoff point 
for the IQ score in our primary outcome, we found 
significant reductions in the rates of moderate-to-
severe cognitive deficiency in the hypothermia 
group, as compared with the control group, but 
similar rates of mortality in the two groups.
Our study was limited by the lack of avail-
ability of primary outcome data for 15% of the 
original TOBY trial population (11% of the hypo-
thermia group and 18% of the control group). 
In anticipation of dropout, we prespecified a sen-
sitivity analysis in which we substituted the Mental 
Developmental Index score at 18 months for the 
missing IQ score in order to examine the robust-
ness of the results. The high correlation for neu-
rologic outcomes between earlier assessment and 
later follow-up that we observed among children 
who had undergone the two assessments, as well 
as correlation with the findings of the CoolCap 
and NICHD studies, provides support for our ap-
proach, and the close agreement of the results of 
the primary and sensitivity analyses increases our 
confidence in the conclusions.
Several children were unable to complete the 
full-scale WPPSI-III or WISC-IV test, in most 
cases because of physical impairments. Assessors 
who were unaware of the study-group assign-
ments classified these children as having an IQ 
score below 85 or an IQ of 85 or higher, which 
allowed them to be included in the primary 
analysis. Almost all these children (all but six) 
were classified as having an IQ score that was 
lower than 85. The results of our primary out-
come analysis were not materially altered when 
all the children without results on full-scale IQ 
testing were classified as having an IQ score of 
less than 85.
We found no significant between-group dif-
ferences for many secondary outcomes assessed, 
including 10 of 11 psychometric test scores. Pri-
oritizing assessment of IQ as the primary out-
come meant that some other tests were curtailed 
if the assessor determined that the child could 
not maintain adequate performance. Thus, our 
study was not adequately powered for many of 
these comparisons. Most point estimates favored 
the hypothermia group, though the differences 
were modest.
In conclusion, our study provides evidence 
that the benefits of moderate hypothermia after 
perinatal asphyxia persist into middle childhood.
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